“…Probably benign breast lesions constitute a subset of mammographically detected lesions that should have such a small risk of being malignant, less than 2%, that imaging follow-up is considered a safe alternative to immediate tissue diagnosis (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13). Identification of these low-risk lesions is an important and frequently used tool of the breast imaging radiologist to avoid unnecessary biopsies, which increase both the morbidity and cost associated with breast cancer screening.…”
Short-term mammographic follow-up is often recommended for lesions that, in retrospect, do not fulfill established diagnostic criteria for probably benign lesions.
“…Probably benign breast lesions constitute a subset of mammographically detected lesions that should have such a small risk of being malignant, less than 2%, that imaging follow-up is considered a safe alternative to immediate tissue diagnosis (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13). Identification of these low-risk lesions is an important and frequently used tool of the breast imaging radiologist to avoid unnecessary biopsies, which increase both the morbidity and cost associated with breast cancer screening.…”
Short-term mammographic follow-up is often recommended for lesions that, in retrospect, do not fulfill established diagnostic criteria for probably benign lesions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.